Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000032067Phase 4Recruiting
Phase 4, randomised trial of remimazolam and propofol in None (2 arms), sponsored by Department of Anesthesiology, the First People's Hospital of Lianyungang City. Primary endpoint: Sedation success rate. Started Apr 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000032067.